Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Omega Diagnostics Group Plc LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  9.00 14.75% 70.00 69.00 72.00 71.00 58.50 60.50 10,484,107 16:35:12
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 9.8 1.2 0.8 87.5 126

Omega Diagnostics Share Discussion Threads

Showing 16176 to 16199 of 19550 messages
Chat Pages: Latest  650  649  648  647  646  645  644  643  642  641  640  639  Older
DateSubjectAuthorDiscuss
29/10/2020
18:14
So L & G have been reducing.....Holding RNS They have gone from 9.14% to under 5% offloaded yesterday and advised today. They could also have offloaded today......
barrywhit
29/10/2020
18:12
And there it is, L&G dumping into liquidity. Crossed 5% yesterday and seller again today. Omega Diagnostics Gp - Holding(s) in Company ODX @OmegaDiagnostic hxxps://t.co/mBbRILEBus
searcher0
29/10/2020
17:57
some big boys reported late, some from yesterday
jusjusjus
29/10/2020
16:24
Er, large seller. Sneller been offloading for months. Do catch up.
coley15
29/10/2020
16:23
Not been wrong on those. You can't have it both ways and it doesn't take a genius to work out if the share price is being pinned it generally means you have a large seller or a placing being worked. In this case it looks to be a seller.
searcher0
29/10/2020
16:21
I think we must surely be a takeover target now Nxc a while ago mentioned novacyt. I'm not sure how serious he was,but he may not be far wrong.
upomega
29/10/2020
15:37
Searchers last input on vast, prem and sml all about placing ahead, says it all really
martin3042
29/10/2020
15:36
Lets see if we get a Holdings RNS, Sneller may be offloading or L&G..David Evans is now below 3% so we won't know about him.... But i expected a small bounce today NCYT up 23% ODX only 2%....disappointing...
barrywhit
29/10/2020
15:12
Well lots of supply coming from somewhere. Price continues to be pinned.
searcher0
29/10/2020
14:59
He nearly blurted it out but then CK bit his tongue. He did not address it again but clear to me that talks of some sort whether customer or other, are underway
carlisle44
29/10/2020
14:52
C44 I didnt catch who the mystery person was he very briefly mentioned and discounted to talk about later?
ant15
29/10/2020
14:39
Searcher0 try listing attentively to yesterday's presentation. Just saying doesn't cut it
carlisle44
29/10/2020
13:49
SEARCHER0 Completely discounted by their CFO in the presentation have sufficient cash to do everything including further factory space and new machinery through to April They are trading profitably but with the new capacity and production will be making substantial profits in The New Year.
ant15
29/10/2020
13:49
Presumably you missed the presentation yesterday where this was explicitly answered? Just saying.
coley15
29/10/2020
13:44
Feels like a placing in the works or a seller the way the share price is pinned here. They may need it to take on the very larger orders. Just saying.
searcher0
29/10/2020
13:33
A rather nice new tweet direct from ODX - with a chart showing capacity increasing to 2m lateral flow tests per week by April: Https://twitter.com/OmegaDiagnostic/status/1321798576129908739/photo/1 "Omega Diagnostics @OmegaDiagnostic ยท 32m By end of 2020 we will have production capacity at our Alva site for 0.5m lateral flow tests a week to match expected demand: ✅ 200k tests a week min for AbC-19 Rapid Tests ✅ some CD4 test production ✅ the rest for Mologic antibody and antigen test production
rivaldo
29/10/2020
12:20
looks like someone has sold.
thehitman1
29/10/2020
12:15
We need a couple of institutions on board.i cant see the price doing much now until the next update which is now a few months away.
upomega
29/10/2020
12:04
Not sure if this has already been posted.https://www.heraldscotland.com/business_hq/18829396.omega-adds-staff-alva-hq-covid-test-production-gears/
xtrmntr
29/10/2020
11:54
The MM's must have quite a few shares to move...hopefully we will start to tick up this afternoon....
barrywhit
29/10/2020
09:24
walking it back up now
thehitman1
29/10/2020
09:21
lots of buys today.
thehitman1
29/10/2020
08:59
Link to the Investor Presentation in the tweet: https://twitter.com/InvestorMeetCo/status/1321534038490992641
barrywhit
29/10/2020
08:36
Looking further ahead, Mr Harbinson said staff numbers could double again to 200 if there is deemed to be sufficient demand for its test kits. Omega hopes to have further clarity on those demand levels by the end of this year. READ MORE: Omega confirms Covid-19 test order volumes “We are exploring how we might take production up to the order of two million tests per week,” he said. “If we were doing that I think we would be looking to mid-April as a timeframe.” Shares in AIM-listed Omega fell yesterday after the company revealed a 29 per cent drop in turnover for the first six months of the year. The expected decline in revenues to just less than £3.2m was driven by a 38% fall in its dominant food intolerance testing division, which suffered as global health priorities focused on the pandemic. As a result, earnings for the period – as calculated before interest, tax, depreciation and amortisation – will come in at a loss of approximately £1.3m. Mr Harbinson said there has since been a recovery in demand for food intolerance testing, with a rebound in orders coming from across Europe, the Middle East and Latin America. Sales in October are expected to be approximately 20% higher on the same period last year. READ MORE: Full launch this month as Omega gets Covid test approval Omega said it believes there are significant near-term opportunities for this business unit in China, where it is awaiting confirmation of regulatory approval of a self-test version of its Food Detective kit. The company is also looking to access the US market. Earlier this month, the UK Rapid Test Consortium (UK-RTC) of which Omega is a member announced the UK Government had placed its first order for one million rapid AbC-19 antibody tests, which detect whether an individual has been previously infected by the coronavirus. Omega will manufacture approximately 175,000 of the first one million tests, and will produce “not less” than 25% of the demand from total orders placed over the term of the Government supply agreement. The company is also working on a rapid antibody test with Bedfordshire-based Mologic, as well as a rapid antigen test to detect those currently infected by the coronavirus. Both are lateral flow tests – similar to a home pregnancy test – which produce immediate results at the point where the test is taken. READ MORE: Omega Diagnostics gets key clearance for HIV tests The Mologic antibody test is said to be gaining “early sales traction” that “provides confidence for performance in the second half of the year”. A prototype of the Mologic antigen test is currently in evaluation “in a number of healthcare settings”, with the results to date looking “promisingR21;. By contrast, the Mologic ELISA antibody test, which must be sent away to a lab to procure results, has failed to gain the levels of traction initially anticipated. Mr Harbinson said it appears to be getting “squeezed out” between similar lab tests from larger competitors that can run on much higher volume equipment, and a broader market preference for lateral flow tests that produce fast results. As a “mitigating strategy”, Omega is looking at whether to offer its ELISA test to healthcare practitioners in the UK, with the results processed at its laboratory in Littleport, Cambridgeshire. Elsewhere, the company has received a number of purchase orders from Uganda and Mozambique for its Visitect CD4 test to help manage the care of patients with HIV. These have been channelled through a supply agreement signed earlier this year with the Clinton Health Access Initiative. Omega will announce its half-year results on November 30. Its shares closed yesterday’s trading down 18.5p at 74p.
barrywhit
Chat Pages: Latest  650  649  648  647  646  645  644  643  642  641  640  639  Older
ADVFN Advertorial
Your Recent History
LSE
ODX
Omega Diag..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210124 04:15:43